Sr. No.	Received from	Pending at the end of last month	Received	Resolved*	Total Pending #	Pending complaints >3months	Average Resolution time^ (in days)
1	Directly from Investors	0	0	0	0	0	0
2	SEBI (SCORES)	0	0	0	0	0	0
3	Other Sources (if any)	0	0	0	0	0	0
	Grand Total	0	0	0	0	0	0

Sr. No.	Month	Carried forward from previous month	Received	Resolved*	Pending#
1	Jun, 2026	0	0	0	0
2	Jul, 2026	0	0	0	0
3	Aug, 2026	0	0	0	0
	Grand Total	0	0	0	0

Sr. No.	Fin. Year	Received	Resolved*
1	2022-23	1	1
2	2023-24	0	0
3	2024-25	0	0
4	2025-26	1	1
	Grand Total	2	2

Top Pharma Companies in India by Market Cap

BSE Sensex 74459.53 308.49 (0.42%)

Filter

Top Pharma Companies in India as on Nov-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

Expand company details	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)	More company information
1	Sun Pharmaceutical Industries Ltd.	Q V+ PT	4,26,662 Large Cap	1,778.25 (0.87%)	38.91	4.78	11.78	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Divis Laboratories Ltd.	Q V+ PT	2,57,903 Large Cap	9,715 (0.62%)	88.17	14.6	8.67	4.44	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Torrent Pharmaceuticals Ltd.	Q V+ PT	1,76,306 Large Cap	4,635.15 (1.56%)	83.01	9.6	11.80	13.74	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Laurus Labs Ltd.	Q V+ PT	1,29,243 Mid Cap	2,392 (6.55%)	96.46	21.33	7.19	-2.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	Zydus Lifesciences Ltd.	Q V PT	1,24,089 Mid Cap	1,244 (4.89%)	27.5	4.6	13.52	14.72	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Apollo Hospitals Enterprise Ltd.	Q V+ PT	1,20,779 Large Cap	8,400 (2.46%)	76.88	11.71	14.92	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Dr. Reddys Laboratories Ltd.	Q V PT	1,12,699 Mid Cap	1,350.20 (0.87%)	40.25	2.9	12.09	15.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Cipla Ltd.	Q V PT	1,11,489 Large Cap	1,380 (1.69%)	38.48	3.15	8.01	10.07	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Mankind Pharma Ltd.	Q V PT	1,02,797 Mid Cap	2,488.75 (1.12%)	45.84	5.85	18.10	8.40	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Aurobindo Pharma Ltd.	Q V+ PT	96,537 Mid Cap	1,677.80 (1.38%)	37.23	4.12	-6.73	-4.90	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Lupin Ltd.	Q V PT	91,870 Mid Cap	2,009 (0.55%)	16.62	3.86	13.02	32.37	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Manipal Health Enterprises Ltd.	Q V+ PT	87,926 Mid Cap	668.45 (4.63%)	98.54	5.3	41.64	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Max Healthcare Institute Ltd.	Q V PT	83,706 Mid Cap	860 (1.00%)	60.63	7.39	27.27	155.29	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Glenmark Pharmaceuticals Ltd.	Q V+ PT	65,137 Mid Cap	2,308 (-1.07%)	36.23	5.94	9.19	22.19	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Alkem Laboratories Ltd.	Q V PT	61,277 Mid Cap	5,125 (1.49%)	28.4	4.28	10.66	8.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Aster DM Quality Care Ltd.	Q V+ PT	59,570 Mid Cap	683.40 (0.66%)	186.93	14.08	-11.61	19.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
17	Fortis Healthcare Ltd.	Q V+ PT	58,117 Mid Cap	769.80 (2.16%)	55.46	5.72	17.76	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
18	Biocon Ltd.	Q V PT	57,365 Mid Cap	352 (0.00%)	587.16	2.1	2.96	-18.61	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
19	Abbott India Ltd.	Q V PT	54,384 Mid Cap	25,593.30 (-1.97%)	33.68	10.51	9.96	17.33	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
20	Gland Pharma Ltd.	Q V PT	51,112 Mid Cap	3,097.50 (0.74%)	45.28	4.81	13.18	0.09	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
21	Ipca Laboratories Ltd.	Q V+ PT	48,907 Mid Cap	1,927.70 (0.10%)	39.32	5.86	7.35	1.36	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
22	Anthem Biosciences Ltd.	Q V PT	46,685 Mid Cap	828.45 (-0.31%)	81.06	14.92	14.00	16.46	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
23	Ajanta Pharma Ltd.	Q V+ PT	43,891 Mid Cap	3,512.40 (1.52%)	34.76	9.03	13.54	10.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
24	Glaxosmithkline Pharmaceuticals Ltd.	Q V PT	42,073 Mid Cap	2,483.55 (-1.28%)	39.39	16.69	5.49	17.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
25	Emcure Pharmaceuticals Ltd.	Q V PT	35,440 Small Cap	1,868.10 (0.23%)	35.04	6.78	8.73	13.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
26	Narayana Hrudayalaya Ltd.	Q V PT	35,144 Small Cap	1,719.70 (0.32%)	40.92	7.02	25.04	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
27	Global Health Ltd.	Q V PT	34,122 Small Cap	1,269.05 (-2.32%)	61.35	8.3	24.97	76.92	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
28	Sai Life Sciences Ltd.	Q V+ PT	33,139 Small Cap	1,559.70 (4.33%)	91.61	12.98	23.61	39.96	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
29	Acutaas Chemicals Ltd.	Q V+ PT	32,770 Small Cap	4,002.65 (0.53%)	74.62	17.64	31.50	70.35	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
30	Dr. Lal Pathlabs Ltd.	Q V PT	31,997 Small Cap	1,906.30 (-0.37%)	58.73	12.44	12.18	13.26	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Anuh Pharma	87.09	8.86%
Laurus Labs	2,392	6.55%
SMS Pharmaceuticals	511.75	5.33%
Wanbury	189.75	5.10%
Zydus Lifesciences	1,244	4.89%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
RPG Life Sciences	2,572.40	-14.13%
Thyrocare Tech.	457	-11.30%
Gennex Laboratories	8.02	-10.49%
Ind-Swift Labs.	367.40	-10.14%
Cohance Lifesciences	444.45	-7.67%

News about Top Pharma Companies in India

Oct, 2026

Manipal Health Enterprises informs about disclosure

Manipal Health Enterprises has informed that it enclosed Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on October 30, 2026 for MEMG International India.

The above information is a part of company’s filings submitted to BSE.

Oct, 2026

Sun Pharma. Inds. - Quaterly Results

The sales surged to Rs. 61419.20 millions, up 35.04% for the September 2026 quarter as against Rs. 45481.10 millions during the corresponding quarter previous year.Profit after tax for the quarter ended September 2026 reported a huge growth of 54.42% to Rs. 8712.90 millions from Rs. 5642.20 millions.Operating Profit saw a handsome growth to 17957.40 millions from 12563.80 millions in the quarter ended September 2026.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	61419.20	45481.10	35.04	118830.50	101429.90	17.16	207546.40	229774.00	-9.67
Other Income	810.10	727.90	11.29	2211.80	1765.00	25.31	4193.30	3791.40	10.60
PBIDT	17957.40	12563.80	42.93	39001.20	32696.20	19.28	66000.20	72168.40	-8.55
Interest	2769.60	2483.30	11.53	5554.40	4867.50	14.11	9478.40	9538.90	-0.63
PBDT	15187.80	10080.50	50.67	33131.50	24952.30	32.78	51058.40	62629.50	-18.48
Depreciation	3157.90	3363.00	-6.10	6237.10	6472.20	-3.63	13117.20	12867.40	1.94
PBT	12029.90	6717.50	79.08	26894.40	18480.10	45.53	37941.20	49762.10	-23.75
TAX	3317.00	1075.30	208.47	7030.10	5387.30	30.49	11707.00	7481.30	56.48
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
PAT	8712.90	5642.20	54.42	19864.30	13092.80	51.72	26234.20	42280.80	-37.95
Equity	2399.30	2399.30	0.00	2399.30	2399.30	0.00	2399.30	2399.30	0.00
PBIDTM(%)	29.24	27.62	5.84	32.82	32.24	1.82	31.80	31.41	1.25

Oct, 2026

Ajanta Pharma - Quaterly Results

The sales moved up 41.37% to Rs. 17250.70 millions for the September 2026 quarter as compared to Rs. 12202.40 millions during the year-ago period.Profit after tax for the quarter ended September 2026 reported a huge growth of 52.24% to Rs. 3798.90 millions from Rs. 2495.30 millions.Operating Profit saw a handsome growth to 5697.10 millions from 3646.20 millions in the quarter ended September 2026.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	17250.70	12202.40	41.37	32137.40	24288.00	32.32	48459.20	43220.40	12.12
Other Income	526.20	750.30	-29.87	1234.40	1156.60	6.73	2044.00	1198.70	70.52
PBIDT	5697.10	3646.20	56.25	10372.30	7346.50	41.19	14023.90	13245.90	5.87
Interest	7.90	7.30	8.22	15.50	14.60	6.16	25.90	46.00	-43.70
PBDT	5689.20	3638.90	56.34	10356.80	7331.90	41.26	13998.00	13199.90	6.05
Depreciation	463.00	419.20	10.45	896.10	822.30	8.97	1687.70	1399.30	20.61
PBT	5226.20	3219.70	62.32	9460.70	6509.60	45.33	12310.30	11800.60	4.32
TAX	1427.30	724.40	97.03	2507.10	1464.60	71.18	2842.10	2631.70	7.99
Deferred Tax	-158.10	64.70	-344.36	-94.60	97.60	-196.93	76.00	51.40	47.86
PAT	3798.90	2495.30	52.24	6953.60	5045.00	37.83	9468.20	9168.90	3.26
Equity	250.70	250.70	0.00	250.70	250.70	0.00	250.70	250.70	0.00
PBIDTM(%)	33.03	29.88	10.52	32.27	30.25	6.70	28.94	30.65	-5.57

Oct, 2026

Max Healthcare Inst. - Quaterly Results

The company witnessed a 14.30% growth in the revenue at Rs. 8419.70 millions for the quarter ended September 2026 as compared to Rs. 7366.20 millions during the year-ago period.Profit for the quarter ended September 2026 grew by 4.93% to Rs. 1683.30 millions from Rs. 1604.20 millions.Operating profit surged to 2786.40 millions from the corresponding previous quarter of 2611.00 millions.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	8419.70	7366.20	14.30	16248.90	14306.40	13.58	28744.50	26636.00	7.92
Other Income	491.10	474.30	3.54	1412.10	1272.80	10.94	3019.50	3665.40	-17.62
PBIDT	2786.40	2611.00	6.72	5532.20	5286.60	4.65	11225.30	11999.30	-6.45
Interest	137.20	86.70	58.25	257.90	179.20	43.92	398.70	483.90	-17.61
PBDT	2649.20	2524.30	4.95	5274.30	5107.40	3.27	10670.20	10779.10	-1.01
Depreciation	387.70	367.70	5.44	753.70	722.00	4.39	1429.00	1311.90	8.93
PBT	2261.50	2156.60	4.86	4520.60	4385.40	3.08	9241.20	9467.20	-2.39
TAX	578.20	552.40	4.67	1161.30	1120.90	3.60	2075.10	2456.50	-15.53
Deferred Tax	-28.30	50.80	-155.71	-17.10	77.10	-122.18	196.70	482.90	-59.27
PAT	1683.30	1604.20	4.93	3359.30	3264.50	2.90	7166.10	7010.70	2.22
Equity	9733.10	9722.40	0.11	9733.10	9722.40	0.11	9731.30	9721.40	0.10
PBIDTM(%)	33.09	35.45	-6.64	34.05	36.95	-7.86	39.05	45.05	-13.31

Oct, 2026

Narayana Hrudayalay. - Quaterly Results

The revenue zoomed 16.31% to Rs. 11853.77 millions for the quarter ended September 2026 as compared to Rs. 10191.69 millions during the corresponding quarter last year.Good Net Profit growth of 27.38% reported above the corresponding previous quarter figure of Rs. 1378.80 millions to Rs. 1756.26 millioins.Operating profit for the quarter ended September 2026 rose to 3045.61 millions as compared to 2461.39 millions of corresponding quarter ended September 2025.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202609	202509	% Var	202609	202509	% Var	202603	202503	% Var
Sales	11853.77	10191.69	16.31	22824.79	19623.10	16.32	39751.41	35901.22	10.72
Other Income	433.50	170.88	153.69	737.63	335.24	120.03	1764.34	1421.63	24.11
PBIDT	3045.61	2461.39	23.74	5740.96	4415.93	30.01	10158.82	8137.02	24.85
Interest	352.30	285.78	23.28	688.96	592.01	16.38	1271.16	877.08	44.93
PBDT	2693.31	2175.61	23.80	5052.00	3823.92	32.12	8434.90	7259.94	16.18
Depreciation	501.09	462.66	8.31	982.57	938.24	4.72	1914.78	1692.63	13.12
PBT	2192.22	1712.95	27.98	4069.43	2885.68	41.02	6520.12	5567.31	17.11
TAX	435.96	334.15	30.47	934.62	633.17	47.61	1488.99	1255.89	18.56
Deferred Tax	17.03	18.36	-7.24	34.58	30.77	12.38	-75.93	187.21	-140.56
PAT	1756.26	1378.80	27.38	3134.81	2252.51	39.17	5031.13	4311.42	16.69
Equity	2043.61	2043.61	0.00	2043.61	2043.61	0.00	2043.61	2043.61	0.00
PBIDTM(%)	25.69	24.15	6.39	25.15	22.50	11.77	25.56	22.67	12.75

Oct, 2026

Max Healthcare Institute reports 16% fall in Q2 consolidated net profit

The total consolidated income of the company has increased by 20.37% at Rs 2,610.11 crore for Q2FY27

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	Sun Pharmaceutical Industries Ltd.	4,26,662 Crore
2	Divis Laboratories Ltd.	2,57,903 Crore
3	Torrent Pharmaceuticals Ltd.	1,76,306 Crore
4	Laurus Labs Ltd.	1,29,243 Crore
5	Zydus Lifesciences Ltd.	1,24,089 Crore
6	Apollo Hospitals Enterprise Ltd.	1,20,779 Crore
7	Dr. Reddys Laboratories Ltd.	1,12,699 Crore
8	Cipla Ltd.	1,11,489 Crore
9	Mankind Pharma Ltd.	1,02,797 Crore
10	Aurobindo Pharma Ltd.	96,537 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,593	54,384	33.68	10.51	23.07	34.24
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,635	1,76,306	83.01	9.60	33.08	29.04
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,308	65,137	36.23	5.94	12.08	27.89
Lupin Ltd. (M)	Somewhat Good	2,009	91,870	16.62	3.86	9.20	26.43
Ajanta Pharma Ltd. (M)	Very Good	3,512	43,891	34.76	9.03	23.33	25.35

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	2,392	1,29,243	147
Sai Life Sciences Ltd. (S)	Somewhat Good	1,560	33,139	69.37
Gland Pharma Ltd. (M)	Very Good	3,098	51,112	61.94
Aurobindo Pharma Ltd. (M)	Very Good	1,678	96,537	52.18
Ipca Laboratories Ltd. (M)	Very Good	1,928	48,907	49.58
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,560	33,139	91.61	12.98	47.25	23.61
Mankind Pharma Ltd. (M)	Very Good	2,489	1,02,797	45.84	5.85	24.28	18.10
Ajanta Pharma Ltd. (M)	Very Good	3,512	43,891	34.76	9.03	23.33	13.54
Zydus Lifesciences Ltd. (M)	Very Good	1,244	1,24,089	27.50	4.60	15.32	13.52
Gland Pharma Ltd. (M)	Very Good	3,098	51,112	45.28	4.81	23.17	13.18

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Sai Life Sciences Ltd. (S)	Somewhat Good	1,560	33,139	91.61	12.98	47.25	39.96
Lupin Ltd. (M)	Somewhat Good	2,009	91,870	16.62	3.86	9.20	32.37
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,308	65,137	36.23	5.94	12.08	22.19
Abbott India Ltd. (M)	Very Good	25,593	54,384	33.68	10.51	23.07	17.33
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,350	1,12,699	40.25	2.90	18.79	15.75

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Current Complaints

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the month.

*Inclusive of complaints of previous months resolved in the current month. #Inclusive of complaints pending as on the last day of the year.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Manipal Health Enterprises informs about disclosure

Sun Pharma. Inds. - Quaterly Results

Ajanta Pharma - Quaterly Results

Max Healthcare Inst. - Quaterly Results

Narayana Hrudayalay. - Quaterly Results

Max Healthcare Institute reports 16% fall in Q2 consolidated net profit

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?